Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

The S&P 500's recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said ...

Capital One Financial (NYSE:COF) stock was rising after BTIG upgraded the credit card and auto lender on Discover Financial ...

BTIG says Rocket Companies (RKT) is acquiring Mr. Cooper (COOP) in an all-stock deal valuing Cooper at roughly $143 ore share, plus a $2 cash ...

Investing.com -- BTIG downgraded Ally Financial (NYSE:ALLY) Inc to Sell from Neutral with a $30 target saying a challenging macroeconomic condition and increased competition in the auto lending ...

Investing.com -- BTIG raised its CrowdStrike (NASDAQ: CRWD) stock rating to Buy from Neutral on Tuesday, pointing to improved ...

CrowdStrike (CRWD) was upgraded from Neutral to Buy by BTIG, and maintains a $431 price target on the stock. Market Domination hosts Julie Hyman and Josh Lipton break down BTIG's reasons for the ...

On Monday, BTIG analysts maintained a Neutral rating on Venus Concept Inc. (NASDAQ:VERO) after the company reported lower-than-expected Q4 revenue. Venus Concept disclosed a quarterly revenue of $ ...